(FY)Dec 31, 2022 | |
---|---|
Operating Cash Flow (Indirect Method) | |
Cash flow from continuing operating activities | -452.66K |
Net income from continuing operations | ---557.75K |
Change In working capital | --105.09K |
-Change in receivables | ---24.21K |
-Change in payables and accrued expense | --129.3K |
Cash from discontinued investing activities | |
Operating cash flow | ---452.66K |
Investing cash flow | |
Cash flow from continuing investing activities | -217.66K |
Net PPE purchase and sale | ---150K |
Net investment purchase and sale | ---67.66K |
Cash from discontinued investing activities | |
Investing cash flow | ---217.66K |
Financing cash flow | |
Cash flow from continuing financing activities | 822.5K |
Net issuance payments of debt | --20K |
Net common stock issuance | --0 |
Net other financing activities | --802.5K |
Cash from discontinued financing activities | |
Financing cash flow | --822.5K |
Net cash flow | |
Beginning cash position | --14.18K |
Current changes in cash | --152.18K |
End cash Position | --166.36K |
Free cash from | ---602.66K |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.